Demonstration study of the TCM intervention based with 'treatment before disease onset' theory on population with high-risk of osteoporosis

Bejing University of Chinese Medicine Third Affiliated Hospital0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•(1) The population aged 40-70 years;
•(2) Those who have risk factors of osteoporosis;
•(3) Results of IOF 1 minute osteoporosis test are positive;
•(4) The result of BMD test is reduced(-2.5 (5) Those with normal or abnormal bone metabolism and biochemical indicators.

•(1) People who are known or suspected to be allergic to the drugs of the research;
•(2) A variety of sports contraindications (acute stages of diseases such as heart and lung diseases, bleeding-prone diseases such as gastrointestinal bleeding);
•(3) Patients with osteoporosis;
•(4) Bone metastases from malignant tumors;
•(5) Long-term use of drugs that affect bone metabolism;
•(6) Patients who are using other intervention drugs or suffering from other diseases that may interfere with the evaluation of safety or effectiveness of the drug;
•(7) Patients with severe primary diseases such as cardiovascular, cerebrovascular and hematopoietic diseases, and mental illness, and those who are still taking hormones and those whose results of liver and kidney function tests are abnormal(values higher than the upper limit of normal values);
•(8) Women preparing for pregnancy,or pregnancy, or lactation;
•(9) Researchers consider it inappropriate to be selected for this trial.

发起方

Bejing University of Chinese Medicine Third Affiliated Hospital